HempWorx 500 Broad Spectrum CBD Oil Peppermint Review
HempWorx 500 Broad Spectrum CBD Oil Peppermint is listed on this SuppCo product page as a liquid supplement. The page identifies the brand as HempWorx and the product as 500 Broad Spectrum CBD Oil Peppermint. According to the page summary, the product has not yet been scored with a complete product TrustScore, and the TrustScore section currently reads Unrated because the system has insufficient data to evaluate it. A link labeled Request score is provided for users who want to request a priority trust score for this product. The page lists a serving size of 0.6 mL, with 50 servings per container. The price per serving is shown as $0.00 and the listed price is also $0.00, which the page presents as placeholder values rather than a confirmed retail price. The format is listed as liquid. The product page also includes a Shop button and an Add to stack button, which allow visitors to act on the listing within the SuppCo site. The nutrition section lists Hemp-Derived Broad Spectrum CBD at 10mg per serving. It also lists 9 calories and 1g of total fat, along with a line for calories from fat showing 9 calories. The page summary states that the key active ingredient is hemp-derived broad spectrum CBD. It describes the product as backed by ISO 17025-accredited third-party testing and states that the inactive ingredient profile is none. It also notes that product-specific testing is not currently verified by SuppCo. The suggested use instructions say to use up to one dropper, which equals 0.6 ml, twice a day. The instructions say to place the drops under the tongue, hold them there for 60 seconds, and then swallow. No customer reviews, star ratings, or written feedback appear on this page. The page displays the brand HempWorx with a brand rating of 7.38 in its header, but the product itself is marked Unrated. The related products section is still loading on the scraped version of the page, and a splash screen and a taking longer than expected message appear in the captured text, along with a reload option and a support contact link. The page includes a standard disclaimer stating that the statements have not been evaluated by the Food and Drug Administration and that the products and informational content are not intended to diagnose, treat, cure, or prevent any disease. Visitors are directed to a Go Home link and a contact email for support. No barcode, UPC, EAN, or GTIN is printed in the scraped text for this bottle, so none is reported here.
Study, Trial or Testing Result Summary
Members Only64 human studies · 23 improved
This oil's main ingredient is cannabidiol, but the label does not say how much is in each serving, so it cannot be compared with the doses studied. Research on cannabidiol for anxiety is mixed. A 2024 review pooling eight studies of 316 people with anxiety disorders linked it to a large drop in anxiety, though the total number of people was small [1]. A 2024 placebo-controlled trial of 178 adults with mild to moderate anxiety found that 15 weeks of a cannabidiol drink lowered anxiety more than placebo, with no serious side effects [2]. Single large doses of 300 to 600 milligrams calmed people during a public speaking test, including people with social anxiety [3] and people with Parkinson's disease [4], and helped runners feel calmer [5]. These single doses are much larger than most oil servings provide. Other trials found no calming effect. In 136 adults with arthritis, 20 to 30 milligrams a day for 12 weeks did not change anxiety, sleep, mood or pain compared with placebo [6]. Small trials in test anxiety and trauma recall also found no benefit. Animal and cell studies are never counted.
See all 64 studies →Hide the studies
- Across 152 trials with 12,123 people, cannabidiol clearly helped epilepsy and Parkinsonism, but the review did not report a clear calming or stress benefit for cannabidiol.Medical cannabinoids: a pharmacology-based systematic review and meta-analysis for all relevant medical indications.
- In 40 trials with 3,067 people, THC with or without cannabidiol slightly eased anxiety in people with other medical conditions (very low quality evidence), but few trials tested cannabidiol alone and evidence for mental disorders was scarce.Cannabinoids for the treatment of mental disorders and symptoms of mental disorders: a systematic review and meta-analys…
- In 14 studies with 1,823 adults with cancer pain, cannabis-based medicines including cannabidiol oil did not relieve pain meaningfully, and the review did not report on stress or calmness for cannabidiol.Cannabis-based medicines and medical cannabis for adults with cancer pain.
- Pooling eight studies with 316 people with anxiety disorders, cannabidiol was linked to a large reduction in anxiety, though the small sample means the result should be read with caution.Therapeutic potential of cannabidiol (CBD) in anxiety disorders: A systematic review and meta-analysis.
- Six case reports and seven trials with 201 people found weak evidence that cannabidiol may ease social anxiety, with mostly mild side effects like sedation and dizziness.Is there a role for cannabidiol in psychiatry?
- A review of 35 studies across 13 conditions found 23 reported significant improvement in main outcomes, including anxiety, at doses under 1 to 50 mg per kg daily, but no benefit appeared in small trials of several other conditions that used low doses.A systematic review of cannabidiol dosing in clinical populations.
- A review of 27 randomized trials found limited evidence on cannabidiol for psychiatric disorders, with possible benefits for anxiety, psychosis and substance use, and a need for larger trials.Cannabidiol (CBD) use in psychiatric disorders: A systematic review.
- A review of eight small studies (six randomized trials) found oral or sublingual cannabidiol at 6 to 400 mg per dose improved anxiety scores in healthy volunteers and in people with anxiety disorders, and was well tolerated, with fatigue and sedation the most common side effects.Use of cannabidiol in anxiety and anxiety-related disorders.
- This review found tentative support for cannabidiol reducing social anxiety, but evidence for psychiatric use overall is early and too limited to recommend.Medicinal cannabis for psychiatric disorders: a clinically-focused systematic review.
- Nine studies in people with autism found cannabis products reduced symptoms including anxiety and restlessness, but controlled placebo trials are still needed.Cannabis and cannabinoid use in autism spectrum disorder: a systematic review.
- Across 49 controlled studies, high doses of cannabidiol were most consistently followed by some short-term relief of anxiety, but no study showed lasting benefit and bias risk was common.The differential effects of medicinal cannabis on mental health: A systematic review.
- A review of 26 randomized trials and 36 open label studies in adults with treatment-resistant anxiety found only preliminary open label evidence for cannabidiol as an add-on, and no clear conclusion on it.Integrative Systematic Review on Pharmacological, Psychotherapeutic, and Neurostimulatory Treatment Options in Treatment…
- In a placebo-controlled trial of 178 adults with mild to moderate anxiety, a nanodispersible cannabidiol oral solution over 15 weeks lowered anxiety scores more than placebo, with no serious adverse events.Evaluation of the efficacy, safety, and pharmacokinetics of nanodispersible cannabidiol oral solution (150 mg/mL) versus…
- In a randomized study of 159 regular cannabis users given a single session of cannabis flower, a balanced THC and CBD product produced less paranoia and anxiety than a THC-dominant product while giving similar positive mood effects, though it was not compared with placebo.Effects of cannabidiol in cannabis flower: Implications for harm reduction.
- In a double-blind placebo-controlled trial of 136 adults with hand osteoarthritis or psoriatic arthritis, 12 weeks of synthetic CBD at 20 to 30 mg daily produced no significant change in sleep, depression, anxiety or pain compared with placebo.Cannabidiol treatment in hand osteoarthritis and psoriatic arthritis: a randomized, double-blind, placebo-controlled tri…
- In 80 military veterans with PTSD, three weeks of smoked cannabis, including a high-CBD preparation, did not improve PTSD symptoms more than placebo.The short-term impact of 3 smoked cannabis preparations versus placebo on PTSD symptoms: A randomized cross-over clinica…
- Adding 300 mg of CBD daily to eight weeks of exposure therapy did not improve fear or treatment outcomes compared with placebo in people with social anxiety or panic disorder with agoraphobia.Cannabidiol enhancement of exposure therapy in treatment refractory patients with social anxiety disorder and panic diso…
- In 78 people with cocaine use disorder, up to 800 mg of CBD daily did not reduce anxiety or cortisol levels compared with placebo over the study.Cannabidiol Effect on Anxiety Symptoms and Stress Response in Individuals With Cocaine Use Disorder: Exploratory Results…
- In 65 overweight adults, 15 mg of hemp-derived CBD daily for six weeks did not significantly change stress resilience compared with placebo, though sleep quality improved within the hemp group.Effects of Hemp Extract on Markers of Wellness, Stress Resilience, Recovery and Clinical Biomarkers of Safety in Overwei…
- In 63 adults with high trait worry, 300 mg of cannabidiol taken daily for 2 weeks lowered physical anxiety symptoms compared with placebo but did not reduce worry, and a single dose had no effect.The effects of cannabidiol on worry and anxiety among high trait worriers: a double-blind, randomized placebo controlled…
- In 61 healthy young adults, a single oral dose of 150, 300, or 600 mg CBD taken 90 minutes before a carbon dioxide air challenge did not reduce self-reported fear, panic symptoms, or heart rate compared with placebo.A double-blind, randomized, placebo-controlled test of the effects of cannabidiol on fear elicited by a 10% carbon dioxi…
- In a placebo-controlled trial of 60 children aged 5 to 11 with autism, a cannabidiol-rich cannabis extract taken for 12 weeks reduced anxiety and psychomotor agitation more than placebo, with few side effects.Evaluation of the efficacy and safety of cannabidiol-rich cannabis extract in children with autism spectrum disorder: ra…
- In a randomized single-session study of 54 young adults who used caffeine daily, CBD doses from 25 to 240 mg combined with caffeine did not meaningfully change self-reported drug effects or anxiety compared with placebo, and no negative effects emerged.A preliminary investigation of the simultaneous effects of cannabidiol and caffeine.
- In a small trial of 33 people at high risk for psychosis, 600 mg of cannabidiol did not change the link between stress-induced cortisol and brain activity during fear processing compared with placebo.Altered relationship between cortisol response to social stress and mediotemporal function during fear processing in peo…
- In 51 adults with cannabis dependence, a 6-day course of nabiximols, containing up to 80 mg cannabidiol daily, reduced cannabis withdrawal severity and cravings more than placebo and kept more people in treatment, but did not reduce long-term cannabis use.Nabiximols as an agonist replacement therapy during cannabis withdrawal: a randomized clinical trial.
- In 51 adults with Parkinson's disease, about 26 mg per day of sublingual CBD for 12 weeks improved one naming test but did not change overall cognition, anxiety, or depression compared with placebo, and no serious side effects occurred.Cannabidiol and cognitive functions/inflammatory markers in Parkinson's disease: A double-blind randomized controlled tr…
- In 50 women with advanced breast cancer, a single 400 mg oral dose of CBD before a scan did not significantly reduce the main anxiety score compared with placebo, but anxiety was lower 2 to 4 hours after dosing.Cannabidiol for Scan-Related Anxiety in Women With Advanced Breast Cancer: A Randomized Clinical Trial.
- In 48 adults trained to fear a coloured box, a single 32 mg dose of cannabidiol given after fear-extinction practice strengthened memory of the extinction learning when tested two days later, compared with placebo.Cannabidiol enhances consolidation of explicit fear extinction in humans.
- Taking 300 mg of CBD daily for one week, either as a first dose or repeated, did not reduce anxiety, distress, or heart rate during trauma recall in 42 trauma-exposed adults compared with placebo.The effects of acute versus repeated cannabidiol administration on trauma-relevant emotional reactivity: A double-blind,…
- In 40 healthy young adults, a single 300 mg dose of cannabidiol did not change self-reported anxiety, but it lengthened attention lapses and increased early responses on a reaction test compared with placebo.The effects of cannabidiol on subjective states, cognition, and psychomotor function in healthy adults: A randomized cli…
- A single 600 mg dose of CBD taken before a simulated public speaking test reduced anxiety in untreated people with social anxiety disorder, bringing their response close to that of healthy controls.Cannabidiol reduces the anxiety induced by simulated public speaking in treatment-naïve social phobia patients.
- In a pilot trial of 35 adults with bipolar depression, cannabidiol added to usual treatment did not beat placebo over 8 weeks overall, though an exploratory analysis found 300 mg per day reduced depression scores from week 2 to week 8.Cannabidiol as an Adjunctive Treatment for Acute Bipolar Depression: A Pilot Study: Le cannabidiol comme traitement d'ap…
- In a double-blind placebo-controlled crossover study of 33 people, smoking CBD-rich marijuana did not change reaction time, stress behaviour, concentration or balance compared with placebo, though the authors advise waiting several hours before driving because THC levels may exceed legal limits.Impact of smoking cannabidiol (CBD)-rich marijuana on driving ability.
- A single 300 mg dose of CBD before recalling a traumatic event reduced the cognitive impairment felt by people with PTSD compared with placebo, but did not change anxiety, alertness, or discomfort.Effects of cannabidiol on symptoms induced by the recall of traumatic events in patients with posttraumatic stress disor…
- A single 300 mg dose of CBD before recalling a trauma reduced anxiety and cognitive impairment in people with PTSD whose trauma was nonsexual, but this effect was not seen in those whose trauma was sexual.The anxiolytic effect of cannabidiol depends on the nature of the trauma when patients with post-traumatic stress disord…
- In a randomized placebo-controlled study of 32 non-clinical volunteers with high paranoid traits, a single 600 mg oral dose of CBD taken before a virtual-reality stress test did not reduce anxiety or persecutory thinking compared with placebo, and showed a non-significant trend toward increased anxiety.The effects of cannabidiol on persecutory ideation and anxiety in a high trait paranoid group.
- In 32 college students with test anxiety, a single oral dose of 150, 300, or 600 mg of CBD did not reduce test anxiety or general anxiety compared with placebo.A Double-Blind, Randomized, Placebo-Controlled Test of the Effects of Cannabidiol on Experiences of Test Anxiety Among C…
- In 31 men with crack-cocaine dependence, 300 mg of CBD per day for 10 days did not reduce craving, anxiety, or depression more than placebo.Cannabidiol for the treatment of crack-cocaine craving: an exploratory double-blind study.
- In 30 adults with primary insomnia, 150 mg of CBD taken nightly for two weeks did not change most sleep measures compared with placebo, but it raised well-being scores.Cannabidiol for moderate-severe insomnia: a randomized controlled pilot trial of 150 mg of nightly dosing.
- In a 12-week crossover trial of 29 autistic children, CBD oil at 10 mg per kg per day did not improve the main social responsiveness score compared with placebo, but parents reported less anxiety, better social relating, and lower parental stress.Effects of Cannabidiol on Social Relating, Anxiety, and Parental Stress in Autistic Children: A Randomized Controlled Cr…
- In 26 recreational cannabis users, a single vaporised dose combining 13.75 mg cannabidiol with 13.75 mg THC caused less anxiety than THC alone, and cannabidiol offset THC-induced anxiety only in people with low baseline anxiety.Cannabis containing equivalent concentrations of delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD) induces less s…
- In 24 people with Parkinson's disease, a single 300 mg dose of cannabidiol reduced anxiety during a simulated public speaking test compared with placebo and also reduced hand tremor amplitude.Effects of acute cannabidiol administration on anxiety and tremors induced by a Simulated Public Speaking Test in patien…
- In a double-blind placebo-controlled crossover study of 24 healthy people, a single 600 mg oral dose of CBD did not change brain responses to emotional faces or experimentally induced anxiety compared with placebo.The acute effects of cannabidiol on emotional processing and anxiety: a neurocognitive imaging study.
- In 24 adults with fibromyalgia over 16 weeks, a 1:1 THC to CBD oil did not significantly change anxiety or depression compared with placebo, though pain and sleep improved more in the cannabis group.Feasibility, Safety and Preliminary Efficacy of 1:1 THC:CBD Cannabis Oil for Fibromyalgia Symptoms: Results From a Rando…
- In a crossover trial of 22 adults with severe Tourette syndrome, six weeks of an oral THC and cannabidiol oil reduced tics more than placebo, possibly lowering anxiety, but caused slowed thinking, memory lapses and poor concentration in some people.Tetrahydrocannabinol and Cannabidiol in Tourette Syndrome.
- In 17 healthy volunteers, a single 600 mg oral dose of CBD before ayahuasca did not change anxiety differently from placebo, although anxiety fell in both groups.Interactive Effects of Ayahuasca and Cannabidiol in Social Cognition in Healthy Volunteers: A Pilot, Proof-of-Concept, F…
- In 15 healthy men, a single 600 mg dose of cannabidiol showed a trend toward lower anxiety and reduced brain and skin-conductance responses to fearful faces, compared with placebo.Distinct effects of {delta}9-tetrahydrocannabinol and cannabidiol on neural activation during emotional processing.
- A single 600 mg dose of CBD disrupted brain connectivity between the amygdala and anterior cingulate when 15 healthy adults viewed fearful faces, a pattern the authors link to CBD's anxiety-reducing effects.Modulation of effective connectivity during emotional processing by Delta 9-tetrahydrocannabinol and cannabidiol.
- In 14 healthy volunteers, a single 600 mg dose of cannabidiol produced no significant symptom changes compared with placebo, though it changed brain activity during auditory processing.Modulation of auditory and visual processing by delta-9-tetrahydrocannabinol and cannabidiol: an FMRI study.
- In 12 adults with obsessive-compulsive disorder, a single session of smoked cannabis high in cannabidiol did not reduce obsessive-compulsive symptoms more than placebo, and it produced smaller anxiety reductions than placebo.Acute effects of cannabinoids on symptoms of obsessive-compulsive disorder: A human laboratory study.
- A single 300 mg dose of CBD taken two hours before a two-mile run made 12 runners feel more calm and relaxed than placebo and slightly lowered their perceived effort, without changing run time.The Effects of an Acute Dose of Cannabidiol on Health and Two-Mile Time Trial Performance-A Pilot Study.
- In 10 healthy men, a single 400 mg dose of cannabidiol reduced self-reported anxiety and changed activity in brain areas linked to anxiety, compared with placebo.Effects of cannabidiol (CBD) on regional cerebral blood flow.
- In nine adults who smoke cannabis, a low dose of Sativex containing 5 mg CBD over one session did not change the effects of THC on heart rate, anxiety, or good drug effects, and no serious side effects occurred.Subjective and physiological effects after controlled Sativex and oral THC administration.
- In eight healthy volunteers, a single 1 mg/kg dose of CBD blocked the anxiety caused by THC compared with THC alone.Action of cannabidiol on the anxiety and other effects produced by delta 9-THC in normal subjects.
- In an open-label study of 88 adults with chronic pain, 38 people reported at least a 50% drop in anxiety on full-spectrum cannabis extract (THC and CBD), with no control group for comparison.Effectiveness of Full Spectrum Cannabis Extracts in the Treatment of Chronic Pain: An Open Label Study.
- In 40 patients using prescribed medical cannabis, a single self-dosed session had minimal effect on most cognitive tests, and flower vaporized with high THC caused stronger feelings of being stoned and sedated than oils, with no placebo group.A Semi-Naturalistic, Open-Label Trial Examining the Effect of Prescribed Medical Cannabis on Neurocognitive Performance.
- In 33 women with menstrual-related symptoms, taking 320 to 640 mg of CBD per day for five days in each cycle lowered irritability, anxiety, stress, and overall symptom scores over three months, but the study had no placebo group.Examination of the effects of cannabidiol on menstrual-related symptoms.
- In an open-label trial of 31 young people aged 12 to 25 with treatment-resistant anxiety, add-on cannabidiol for 12 weeks reduced anxiety severity, with side effects such as fatigue and low mood.Cannabidiol for Treatment-Resistant Anxiety Disorders in Young People: An Open-Label Trial.
- In an open-label feasibility trial of 18 adults with hand osteoarthritis, a 4% cannabidiol gel applied for four weeks improved anxiety along with pain and grip strength.An open-label feasibility trial of transdermal cannabidiol for hand osteoarthritis.
- In an open-label study of 10 people with Sturge-Weber syndrome, six months of oral cannabidiol improved anxiety and emotional regulation, with mild to moderate side effects.Cannabidiol Treatment for Neurological, Cognitive, and Psychiatric Symptoms in Sturge-Weber Syndrome.
- Among 300 adults with anxiety symptoms over 4 weeks, those using cannabis flower high in cannabidiol had lower anxiety scores than those using high-THC flower, though the study was not a randomized placebo comparison.Acute and Extended Anxiolytic Effects of Cannabidiol in Cannabis Flower: A Quasi-Experimental ad libitum Use Study.
- In a retrospective Canadian clinic study of 279 adults, CBD-rich treatment reduced pain, anxiety and depression symptoms over 3 months in those with moderate to severe symptoms, but mild-symptom patients got worse, and differences between 3 and 6 months were not significant.Cannabidiol use and effectiveness: real-world evidence from a Canadian medical cannabis clinic.
- In a retrospective chart review of 72 adults with anxiety or poor sleep given CBD alongside usual treatment, anxiety scores fell within the first month in 79.2% of patients and stayed lower, while sleep scores improved in 66.7% but fluctuated over time.Cannabidiol in Anxiety and Sleep: A Large Case Series.
- In a case series of two postmenopausal women with osteopenia, 12 weeks of oral cannabidiol showed no notable change in depression, anxiety, stress or sleep disturbance.Oral Cannabidiol Treatment in Two Postmenopausal Women with Osteopenia: A Case Series.
Review Totals and Summary
Members OnlyWhat buyers say
Customer feedback regarding HempWorx CBD oil, including the previously available 500mg broad-spectrum peppermint variant and its 750mg replacement, reveals several recurring qualitative themes. A predominant positive theme is the perceived effectiveness of the oil in addressing various health concerns. Many users have reported significant relief from chronic pain conditions, such as fibromyalgia, arthritis (RA), and severe chronic low back pain. Testimonials frequently highlight the oil's ability to alleviate discomfort and improve overall physical well-being, with some users describing it as a "life saver" for persistent health issues. Beyond pain management, customers often praise HempWorx CBD oil for its positive impact on mental health and sleep quality. Numerous individuals have shared experiences of reduced anxiety and improved mood, with some even reporting the ability to discontinue meds like a med due to the oil's benefits. Better sleep and a feeling of being "alive again" are also commonly cited advantages, suggesting that the product contributes to a greater sense of calm and restorative rest. The peppermint flavor specifically receives positive remarks for its pleasant taste, making daily consumption more enjoyable for users. However, the customer feedback also presents some areas of concern and mixed experiences. A notable point of contention revolves around the potency of the product. While many find it effective, some users have expressed that the HempWorx oil, even at higher doses, did not feel as potent as comparable products from other brands. This suggests that individual responses to CBD can vary, and some customers may require higher concentrations or different formulations to achieve desired effects. Another frequently mentioned aspect, particularly in older discussions, is the brand's multi-level marketing (MLM) business model. While some customers defend the product's efficacy despite the business structure, others voice strong disapproval of the MLM approach, perceiving the products as potentially overpriced due to this model. This indicates that while the product itself may be valued, the sales method can be a deterrent for some consumers. Furthermore, a consistent cautionary theme across various discussions, particularly concerning broad-spectrum products, is the advice regarding drug testing. Even though broad-spectrum CBD is processed to remove detectable THC, retailers and users alike emphasize that no hemp product can guarantee a negative drug test result. This highlights a practical concern for individuals in professions subject to drug screening, prompting them to exercise caution and consult with employers or testing providers before use. Overall, while customers generally laud the product's efficacy for pain, anxiety, and sleep, and appreciate its natural flavor, concerns about potency relative to other brands and the MLM business model are also present in the qualitative feedback.
Biohacker Summary
Members Only10 of 10 recommend it
Only three of the ten panelists spoke about cannabidiol, the main ingredient, and their views were mixed: one recommends it, while two stayed neutral. The one who recommends it uses it for sleep after intense activity, for plane flights, and as a topical gel for sore muscles, and he describes it as helping calm brain inflammation and support detox. His sleep use was about four capsules before bed, in a blend with magnesium, lemon balm, and ashwagandha, and he has also paired it with ashwagandha in a protocol for memory decline. Of the two neutral voices, one calls it one of the most controversial supplements on the market and the other points to an approved use for seizure syndromes in children. No one on the panel reported stopping it or gave a specific caution, and none of them spoke about forms other than capsules and a topical gel.
See all 3 biohackers →Hide the biohackers
Dr. Mark Hyman · Cannabidiol · neutral
- Mentions that GW Pharmaceuticals has an approval for CBD (cannabidiol) for pediatric epilepsy syndromes like Lennox-Gastaut and Dravet syndrome, noting that families had discovered its effectiveness in stopping seizures in their children.
Ben Greenfield · Cannabidiol · recommends
- States that CBD (cannabidiol from hemp) is the most important supplement in the last 30 years for stabilizing glutamate receptors, lowering neuroinflammation, and stimulating endocannabinoid production, making it an excellent adjunct to any detox program or for managing toxic exposure.
- Recommends NatureCBD for cannabidiol and ashwagandha as part of an optimal protocol for reversing Alzheimer's/Dementia.
- Uses a topical gel infused with cannabidiol (CBD) for sore muscles after a race, clarifying it is not THC.
- Ben uses cannabidiol for plane flights.
- Ben takes about four capsules of a cannabidiol capsule, which contains magnesium, lemon balm, ashwagandha, and cannabidiol, before bed to help him sleep after intense activities.
- Came out with a CBD product that is hybrid nano engineered, working with Doctor Mewa to design a water soluble form of cannabidiol.
- Is experimenting with cannabidiols (CBD) in oil form, consuming it sublingually or vaporizing it, for its relaxing and potentially insulin-controlling benefits.
- Considers cannabidiol and CBD extract to be one of the most medicinal and naturally beneficial compounds, consuming it nearly every day for sleep or focus, taking three or four capsules depending on the desired effect.
- Uses cannabidiol (CBD oil) as a healthy, non-addictive alternative to weed, experiencing anti-anxiety and anti-inflammatory effects without the potential for gray matter damage associated with THC.
- Ben states that CBD is one of his supplements of choice and that greenfieldfitnesssystems is producing an organic cannabidiol extract. He notes its use for anxiety, aggressiveness, stress, epileptic seizures, and degenerative joint issues in pets, and its ability to increase the rate at which fractures heal.
Dave Asprey · Cannabidiol · neutral
- Introduces cannabidiol (CBD) as one of the most controversial supplements on the market today and discusses its benefits.
RAL Summary
Members OnlyTier 4 for Stress and Calm
The rules graded this as not working, but the cannabidiol studies disagree, with a pooled review and a 178-person placebo trial showing less anxiety and other trials showing no effect, which fits thin or conflicting evidence rather than proof of no effect. So it is graded Tier 4, as the studies disagree.
- Emerging: not enough evidence to rank higher yet.
Where the evidence disagrees: 21 of the 64 human studies found no effect.
More Details
Members OnlyBody systems · Combine with · Possible side effects
Body systems: Nervous system
Combine with: To enhance the calming and anti-inflammatory effects of CBD, consider combining it with adaptogens like Ashwagandha or Rhodiola for comprehensive stress management. Magnesium can also be synergistic, supporting muscle relaxation and nervous system function. For improved sleep quality, which often correlates with stress reduction, melatonin or L-theanine could be beneficial additions. Omega-3 fatty acids can further support overall cellular health and reduce inflammation, complementing CBD's broader wellness benefits.
Possible side effects: No major side effects reported; the 15-week anxiety trial found no serious side effects.
Supplement Facts
Hemp-Derived Broad Spectrum CBD 10 mg
| Calories | 9 | |
| Calories from Fat | 9 | |
| Total Fat | 1 g | |
| Hemp-Derived Broad Spectrum CBD | 10 mg | † |
Other ingredients: Pressed Hemp seed oil, Hemp-Derived Broad Spectrum CBD, natural Peppermint flavor.
Directions: Suggested use: Use up to 1 dropper (0.6 ml), twice a day. Place drops under the tongue, hold for 60 seconds, then swallow Shake well before use
Label source: NIH label database · Report a label change
Show entire label
Where to Buy
Supp
We sell no supplements. Prices change; check the store.
More stress products
Members OnlyThe highest ranked for the same goal
Read more
Our articles on this subject
- Supplements for Stress and Anxiety Relief: What the Evidence SupportsArticle · Oct 26, 2026
- The Four Pillars of Good Health: Diet, Exercise, Sleep and StressArticle · Mar 17, 2026
Graded November 3, 2026 by the Reverse Age Lab evidence engine, from human studies, real reviews and our biohacker panel. How we grade. Is this medical advice? No. Rala organizes the published evidence; go over any change with your doctor, especially if you take meds.
Privacy policyConsumer health dataTermsDo Not Sell or Share My Personal InformationCookie settings